Compare NMG & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NMG | ANGO |
|---|---|---|
| Founded | 2011 | 1988 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 473.9M | 420.2M |
| IPO Year | 2015 | 2004 |
| Metric | NMG | ANGO |
|---|---|---|
| Price | $1.61 | $12.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $5.75 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 796.6K | 361.1K |
| Earning Date | 05-13-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.92 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $291,010,000.00 |
| Revenue This Year | N/A | $9.51 |
| Revenue Next Year | N/A | $4.96 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $1.37 | $8.36 |
| 52 Week High | $6.06 | $13.99 |
| Indicator | NMG | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 49.29 | 62.22 |
| Support Level | $1.39 | $13.02 |
| Resistance Level | $1.64 | $13.37 |
| Average True Range (ATR) | 0.07 | 0.47 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 89.80 | 68.04 |
Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The Company currently operates in two segments: the Mining projects (which includes the Matawinie Mine project and the Uatnan Mining Project) and the Battery Material Plant project.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.